AlphaYouDM
Insider selling
Duncan Mckechnie sold $800K of Vertex Pharmaceuticals Inc / Ma (VRTX) stock
Duncan Mckechnie, EVP, Chief Commercial Officer of Vertex Pharmaceuticals Inc / Ma (VRTX), sold 1,541 shares of VRTX stock worth $800K, per an SEC Form 4 filed Jul 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 2, 2026, 5 days before it was made public.
VRTX has moved -0.4% since the trade date, from $528.04 to $526.19 (Sep 25, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filing delay
- 5 days
- Price since
- -0.4%
- Role
- EVP, Chief Commercial Officer
- Source
- SEC Form 4
More VRTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.